- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
AASS Antibody (C-term)Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP11094b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP11094b-ev20 | 20 ug 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
AASS Antibody (C-term) - Product info | |
| Application | WB, FC
|
| Primary Accession | Q9UDR5 |
| Other Accession | NP_005754.2 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 102132 Da |
AASS Antibody (C-term) - Additional info | |
| Gene ID 10157 | |
| Other Names AASS; Alpha-aminoadipic semialdehyde synthase, mitochondrial; LKR/SDH; Lysine ketoglutarate reductase; Saccharopine dehydrogenase | |
| Target/Specificity This AASS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 812-841 amino acids from the C-terminal region of human AASS. | |
| Dilution WB~~1:50~100WB~~1:1000 FC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions AASS Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
AASS Antibody (C-term) - Protein Information | |
| Name AASS | |
| Function Bifunctional enzyme that catalyzes the first two steps in lysine degradation. The N-terminal and the C-terminal contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively | |
| Cellular Location Mitochondrion (By similarity). | |
| Tissue Location Expressed in all 16 tissues examined with highest expression in the liver | |
AASS Antibody (C-term) - Related products
AP11094b: AASS Antibody (C-term)
AASS Antibody (C-term) - Application data
-
AASS Antibody (C-term) (Cat. #AP11094b) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the AASS antibody detected the AASS protein (arrow).
-
AASS Antibody (C-term) (Cat. #AP11094b) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
AASS Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia.
REFERENCES
Sacksteder, K.A., et al. Am. J. Hum. Genet. 66(6):1736-1743(2000) Papes, F., et al. Biochem. J. 344 PT 2, 555-563 (1999) :